Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug
<!--[if gte vml 1]>
<![endif]--><!--[if !vml]--><!--[endif]-->
For Immediate Release
December 9, 2013
Contact: Lynda Dee 410-332-1170 or lyndamdee@aol.com
Fair Pricing Coalition
Condemns Gilead Sciences on
the High Price of New
Hepatitis C Drug Sovaldi™, and
Urges Rapid and Wide Dissemination of Support Program Details for
Source: Nelson Vergel's HIV Blog - Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs